TP53 and cancer: Such low binding affinity indicates that (+)-strebloside (1) and strophanthidin (10) do not induce cancer cell apoptosis by directly targeting HDACs, but they may mediate this type of activity by other pathways, including NKA, Nrf2, PI3K, and p53 signaling.